The chronic cough market is expected to reach US$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimated to grow at a CAGR of 7.8% from 2020 to 2027.
Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupting sleep, creating vomiting sensation, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, and gastro esophageal reflux disease (GERD). The chronic cough market growth is attributed to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recalls is the major factor hindering the market growth.
Lucrative Regional Markets for Chronic Cough
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
MarketInsights
Rising Incidences of Chronic Cough
Chronic cough is caused due to asthma, acid reflux from the stomach,and postnasal drip. The conditions such as infection, bronchitis, and lung diseases are also likely to lead to chronic cough. The condition such as asthma is rising across the world; it is commonly seen among children and adults. Itis a major cause of the growing health burden in the US. For instance,according to the Centers for Disease Control and Prevention (CDC) data published in 2019, one among every three people has asthma in the US. Across America, over 25 million people live with asthma, which accounts for ~8% in adults, and nearly 8.5% in children.
In developing regions such as the Asia Pacific and the Middle East and Africa, the prevalence of chronic diseases is rising due to pollution and infections. The countries in these regions are highly populated. Although,cough is a non-communicable disease, it is increasing significantly in the countries. Several governments are putting their efforts to control the incidences of chronic cough in the respective countries. According to the National Health Policy 2017, India, premature mortality due to non-communicable diseases, including chronic cough, will be reduced by ~ 25% by 2025.
In the Middle East and Africa, respiratory diseases are rising due to climatic conditions. The countries surrounded by desserts are prone to the risk of respiratory diseases due to the easy spread of allergens. Over 60 to 70% of patients in the countries are diagnosed with respiratory diseases. Another major cause of chronic cough among people in the region is smoking. Nearly 30%of the people are addicted to smoking, which further leads to rising incidences of chronic cough.
Drug Class Insights
Based on drug class, the chronic cough market is segmented into antihistamines,contortionists, decongestants, combination drug, antibiotics, acid blockers,and other drug class. The combination drug segment held the largest share of the market in 2019 and the same segment is estimated to report the highest CAGR in the market during the forecast period. The growth of the segment is estimated due to benefits offered by the combination drugs such as the use of combination drugs can target treatment more than one symptom. Additionally, the combination of drugs is widely available as over the counter medicines.
Global Chronic Cough Market, by Drug Class – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Route of Administration Insights
Based on rout of administration, the chronic cough market is segmented into oral, injections, inhalation, and other route of administration. The oral segment held the largest share of the market in 2019. However, the inhalation segment is estimated to register the highest CAGR in the market during the forecast period.
Distribution Channel Insights
Based on distribution channel, the chronic cough market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment held the largest share of the market in 2019. However, the online pharmacy segment is estimated to register the highest CAGR in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Chronic Cough Market: Strategic Insights
Market Size Value in US$ 5,430.0 Million in 2019 Market Size Value by US$ 9,854.8 Million by 2027 Growth rate CAGR of 7.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Chronic Cough Market: Strategic Insights
| Market Size Value in | US$ 5,430.0 Million in 2019 |
| Market Size Value by | US$ 9,854.8 Million by 2027 |
| Growth rate | CAGR of 7.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Inorganic strategies are the more commonly adopted strategies by companies in the chronic cough market, which enables them expand their global footprints,and product and service portfolios. The market players have also adopted organic strategies such as product launches strategy to enlarge their global customer base, which also permits them to maintain their brand name globally.
Global Chronic Cough Market – By Drug Class
- Antihistamines
- Corticosteroids
- Decongestants
- Combination Drug
- Antibiotics
- Acid Blockers
- Other Drug Class
Global Chronic Cough Market– By Route of Administration
- Injections
- Oral
- Nasal
- Other Route of Administration
Global Chronic Cough Market– By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Chronic Cough Market– By Geography
North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- South and Central America
- Brazil
- Argentina
Company Profiles
Novartis AG
- Teva Pharmaceutical Industries Ltd
- Glaxo SmithKline plc.
- Bayer AG,
- Mylan N.V.
- Amneal Pharmaceuticals, Inc.
- Cipla Inc.
- Reckitt Benckiser Group plc
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma Ltd
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Class ; Route of Administration ; Distribution Channel ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others.
The growth of market is likely to grow due to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recall is the major factor hindering the market growth.
The cost of chronic cough medicine starts from US$ 2 and above. The price of medicine depends upon the type of drug, whether it is tablet, syrup, or nasal spray. The generic and OTC drugs are much cheaper compared to the branded and prescribed ones.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Chronic Cough Market – By Drug Class
1.3.2 Chronic Cough Market – By Route of Administration
1.3.3 Chronic Cough Market – By Distribution Channel
1.3.4 Global Chronic Cough Market – By Geography
2. Chronic Cough Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Chronic Cough Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America –PEST Analysis
4.2.2 Europe – PESTAnalysis
4.2.3 Asia Pacific–PEST Analysis
4.2.4 Middle East andAfrica – PEST Analysis
4.2.5 South &Central America
4.3 Expert Opinion
5. Chronic Cough Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 RisingIncidences of Chronic Cough
5.1.2 Growing ProductDevelopments to Treat Chronic Cough
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Aging Populationis Expected to Drive Demand for Chronic Cough Treatment
5.4 Future Trends
5.4.1 Continuous Trendof Drug Development
5.5 Impact Analysis
6. Chronic Cough Market – Global Analysis
6.1 Global Chronic Cough Market Revenue Forecast And Analysis
6.2 Global Chronic Cough Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Chronic Cough Market Analysis – By Drug Class
7.1 Overview
7.2 Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
7.3 Antihistamines
7.3.1 Overview
7.3.2 Antihistamines:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Corticosteroids
7.4.1 Overview
7.4.2 Corticosteroids:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Decongestants
7.5.1 Overview
7.5.2 Decongestants:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Combination Drug
7.6.1 Overview
7.6.2 CombinationDrug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Antibiotics
7.7.1 Overview
7.7.2 Antibiotics:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Acid Blockers
7.8.1 Overview
7.8.2 Acid Blockers:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Other Drug Class
7.9.1 Overview
7.9.2 Other DrugClass: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8. Chronic Cough Market – By Route of Administration
8.1 Overview
8.2 Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: ChronicCough Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Injections
8.4.1 Overview
8.4.2 Injections:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Inhalation
8.5.1 Overview
8.5.2 Inhalation:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Other Route of Administration
8.6.1 Overview
8.6.2 Other Route ofAdministration: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)
9. Chronic Cough Market – By Distribution Channel
9.1 Overview
9.2 Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 HospitalPharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Online Pharmacy
9.4.1 Overview
9.4.2 Online Pharmacy:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Retail Pharmacy
9.5.1 Overview
9.5.2 Retail Pharmacy:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
10. Chronic Cough Market – Geographic Analysis
10.1 North America: Chronic Cough Market
10.1.1 Overview
10.1.2 North America:Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
10.1.4 North America:Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
10.1.5 North America:Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
10.1.6 North America:Chronic Cough Market, by Country, 2019 & 2027 (%)
10.1.7 US: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Chronic CoughMarket, by Drug Class, 2018–2027 (USD Million)
10.1.7.3 US: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.1.7.4 US: Chronic Cough Market,by Distribution Channel , 2018–2027 (USD Million)
10.1.8 Canada: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)
10.1.8.3 Canada: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.1.8.4 Canada: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.1.9 Mexico: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)
10.1.9.3 Mexico: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.1.9.4 Mexico: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.2 Europe: Chronic Cough Market
10.2.1 Overview
10.2.2 Europe: ChronicCough Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)
10.2.4 Europe: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.2.5 Europe: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.2.6 Europe: ChronicCough Market, by Country, 2018 & 2027 (%)
10.2.7 Germany: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)
10.2.7.3 Germany: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.2.7.4 Germany: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.2.8 UK: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.2.8.3 UK: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)
10.2.9 France: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: ChronicCough Market, by Drug Class , 2018–2027 (USD Million)
10.2.9.3 France: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.2.9.4 France: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.2.10 Spain: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)
10.2.10.3 Spain: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.2.10.4 Spain: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)
10.2.11 Italy: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)
10.2.11.3 Italy: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.2.11.4 Italy: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)
10.3 Asia Pacific: Chronic Cough Market
10.3.1 Overview
10.3.2 Asia Pacific:Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
10.3.4 Asia Pacific:Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)
10.3.5 Asia Pacific:Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)
10.3.6 Asia Pacific:Chronic Cough Market, by Country, 2019 & 2027 (%)
10.3.7 China: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)
10.3.7.3 China: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.3.7.4 China: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)
10.3.8 Japan: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)
10.3.8.3 Japan: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.3.8.4 Japan: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)
10.3.9 India: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)
10.3.9.3 India: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)
10.3.9.4 India: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)
10.3.10 South Korea: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: ChronicCough Market, by Drug Class , 2018–2027 (USD Million)
10.3.10.3 South Korea: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.3.10.4 South Korea: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.3.11 Australia: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: ChronicCough Market, by Drug Class , 2018–2027 (USD Million)
10.3.11.3 Australia: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)
10.3.11.4 Australia: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.4 Middle East and Africa: Chronic Cough Market
10.4.1 Overview
10.4.2 Middle East andAfrica: Chronic Cough Market- Revenue and Forecast to 2027 (USD Million)
10.4.3 Middle East andAfrica: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
10.4.4 Middle East andAfrica: Chronic Cough Market, by Route of Administration, 2018–2027 (USDMillion)
10.4.5 Middle East andAfrica: Chronic Cough, Market, by Distribution Channel, 2018–2027 (USD Million)
10.4.6 Middle East andAfrica: Chronic Cough Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
10.4.7.3 Saudi Arabia:Chronic Cough Market, by Route of Administration, 2018–2027 (USD Million)
10.4.7.4 Saudi Arabia:Chronic Cough, Market, by Distribution Channel, 2018–2027 (USD Million)
10.4.8 UAE: Chronic CoughMarket– Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Chronic CoughMarket– Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Chronic CoughMarket, by Drug Class, 2018–2027 (USD Million)
10.4.8.3 UAE: Chronic CoughMarket, by Route of Administration, 2018–2027 (USD Million)
10.4.8.4 UAE: Chronic Cough,Market, by Distribution Channel, 2018–2027 (USD Million)
10.4.9 South Africa:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
10.4.9.3 South Africa:Chronic Cough Market, by Route of Administration, 2018–2027 (USD Million)
10.4.9.4 South Africa:Chronic Cough, Market, by Distribution Channel, 2018–2027 (USD Million)
10.5 South and Central America: Chronic Cough Market
10.5.1 Overview
10.5.2 South and CentralAmerica: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 South and CentralAmerica: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)
10.5.4 South and CentralAmerica: Chronic Cough Market, by Route of Administration, 2018–2027 (USDMillion)
10.5.5 South and CentralAmerica: Chronic Cough Market, by Distribution Channel, 2018–2027 (USD Million)
10.5.6 South and CentralAmerica: Chronic Cough Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)
10.5.7.3 Brazil: ChronicCough Market, by Route of Administration, 2018–2027 (USD Million)
10.5.7.4 Brazil: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
10.5.8 Argentina: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)
10.5.8.3 Argentina: ChronicCough Market, by Route of Administration, 2018–2027 (USD Million)
10.5.8.4 Argentina: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Chronic cough Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Chronic Cough Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in The Chronic Cough Market, 2016-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Novartis AG
13.1.1 Key Facts
13.1.2 BusinessDescription
13.1.3 Products andServices
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.2.1 Key Facts
13.2.2 BusinessDescription
13.2.3 Products andServices
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 BusinessDescription
13.3.3 Products andServices
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bayer AG
13.4.1 Key Facts
13.4.2 BusinessDescription
13.4.3 Products andServices
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 MYLAN N.V.
13.5.1 Key Facts
13.5.2 BusinessDescription
13.5.3 Products andServices
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Amneal Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products andServices
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cipla Inc.
13.7.1 Key Facts
13.7.2 BusinessDescription
13.7.3 Products andServices
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Reckitt Benckiser Group plc.
13.8.1 Key Facts
13.8.2 BusinessDescription
13.8.3 Products andServices
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Sun Pharmaceutical Industries Ltd
13.9.1 Key Facts
13.9.2 BusinessDescription
13.9.3 Products andServices
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Aurobindo Pharma Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Chronic Cough Market, by Drug Class – Revenue andForecast to 2027 (USD Million)
Table 2. North America Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USDMillion)
Table 3. North America Chronic Cough Market, by Distribution Channel– Revenueand Forecast to 2027 (USD Million)
Table 4. US Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 5. US Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 6. US Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 7. Canada Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 8. Canada Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 9. Canada Chronic Cough Market, by Distribution Channel– Revenue and Forecastto 2027 (USD Million)
Table 10. Mexico Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 11. Mexico Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 12. Mexico Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 13. Europe Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 14. Europe Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 15. Europe Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 16. Germany Chronic Cough Market, by Drug Class – Revenue and Forecastto 2027 (USD Million)
Table 17. Germany Chronic Cough Market, by Route of Administration– Revenueand Forecast to 2027 (USD Million)
Table 18. Germany Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 19. UK Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 20. UK Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 21. UK Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 22. France Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 23. France Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 24. France Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 25. Spain Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 26. Spain Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 27. Spain Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 28. Italy Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 29. Italy Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 30. Italy Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 31. Asia Pacific Chronic Cough Market, by Drug Class – Revenue andForecast to 2027 (USD Million)
Table 32. Asia Pacific Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific Chronic Cough Market, by Distribution Channel– Revenueand Forecast to 2027 (USD Million)
Table 34. China Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 35. China Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 36. China Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 37. Japan Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 38. Japan Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 39. Japan Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 40. India Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 41. India Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 42. India Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 43. South Korea Chronic Cough Market, by Drug Class – Revenue andForecast to 2027 (USD Million)
Table 44. South Korea Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Chronic Cough Market, by Distribution Channel– Revenueand Forecast to 2027 (USD Million)
Table 46. Australia Chronic Cough Market, by Drug Class – Revenue and Forecastto 2027 (USD Million)
Table 47. Australia Chronic Cough Market, by Route of Administration– Revenueand Forecast to 2027 (USD Million)
Table 48. Australia Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 49. Middle East and Africa Chronic Cough Market, by Drug Class– Revenueand Forecast to 2027 (USD Million)
Table 50. Middle East and Africa Chronic Cough Market, by Route ofAdministration– Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East and Africa Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USDMillion)
Table 52. Saudi Arabia Chronic Cough Market, by Drug Class– Revenue andForecast to 2027 (USD Million)
Table 53. Saudi Arabia Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Chronic Cough Market, by Distribution Channel – Revenueand Forecast to 2027 (USD Million)
Table 55. UAE Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 56. UAE Chronic cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)
Table 57. UAE Chronic Cough Market, by Distribution Channel – Revenue andForecast to 2027 (USD Million)
Table 58. South Africa Chronic Cough Market, by Drug Class– Revenue andForecast to 2027 (USD Million)
Table 59. South Africa Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Chronic Cough Market, by Distribution Channel – Revenueand Forecast to 2027 (USD Million)
Table 61. South and Central America Chronic Cough Market, by Drug Class –Revenue and Forecast to 2027 (USDMillion)
Table 62. South and Central America Chronic Cough Market, by Route ofAdministration – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Chronic Cough Market, by DistributionChannel– Revenue and Forecast to 2027 (USD Million)
Table 64. Brazil Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)
Table 65. Brazil Chronic Cough Market, by Route of Administration – Revenueand Forecast to 2027 (USD Million)
Table 66. Brazil Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 67. Argentina Chronic Cough Market, by Drug Class – Revenue and Forecastto 2027 (USD Million)
Table 68. Argentina Chronic Cough Market, by Route of Administration – Revenueand Forecast to 2027 (USD Million)
Table 69. Argentina Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)
Table 70. Recent Inorganic Growth Strategies in the chronic cough Market
Table 71. Recent Organic Growth Strategies In The Chronic Cough Market
Table 72. Glossary of Terms, Chronic Cough Market
LIST OF FIGURES
Figure 1. Chronic Cough Market Segmentation
Figure 2. Chronic Cough Market – By Geography
Figure 3. Global Chronic Cough Market Overview
Figure 4. Combination Drug Segment Held Largest Share of Chronic Cough Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Global Chronic Cough Market, By Geography (US$ Million)
Figure 7. Global Chronic Cough Market, Industry Landscape
Figure 8. Global Chronic Cough Market- Leading Country Markets (US$ Million)
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Chronic Cough Market Impact Analysis of Drivers and Restraints
Figure 16. Global Chronic Cough Market – Revenue Forecast And Analysis – 2019-2027
Figure 17. Global Chronic Cough Market – By Geography Forecast and Analysis –2019- 2027
Figure 18. Market Positioning of Key Players
Figure 19. Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
Figure 20. Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 21. Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 22. Decongestants: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 23. Combination Drug: Chronic Cough Market – Revenue and Forecast to2027 (US$ Million)
Figure 24. Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 25. Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 26. Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 27. Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
Figure 28. Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)
Figure 29. Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)
Figure 30. Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)
Figure 31. Other Route of Administration: Chronic Cough Market – Revenue andForecast to 2027 (US$ Million)
Figure 32. Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
Figure 33. Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to2027 (US$ Million)
Figure 34. Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 35. Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)
Figure 36. North America: Chronic Cough Market, by Key Country – Revenue (2019)(USD Million)
Figure 37. North America Chronic Cough Market Revenue and Forecast to 2027 (USDMillion)
Figure 38. North America: Chronic Cough Market, by Country, 2019 & 2027 (%)
Figure 39. US: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 40. Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 41. Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 42. Europe: Chronic Cough Market, by Key Country – Revenue (2019) (USDMillion)
Figure 43. Europe Chronic Cough Market Revenue and Forecast to 2027 (USDMillion)
Figure 44. Europe: Chronic Cough Market, by Country, 2018 & 2027 (%)
Figure 45. Germany: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 46. UK: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 47. France: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 48. Spain: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 49. Italy: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 50. Asia Pacific: Chronic Cough Market, by Key Country – Revenue (2019)(USD Million)
Figure 51. Asia Pacific Chronic Cough Market Revenue and Forecast to 2027 (USDMillion)
Figure 52. China: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 53. Japan: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 54. India: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 55. South Korea: Chronic Cough Market – Revenue and Forecast to 2027(USD Million)
Figure 56. Australia: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 57. Middle East and Africa: Chronic Cough Market, by Key Country –Revenue (2019) (USD Million)
Figure 58. Middle East and Africa Chronic Cough Market Revenue and Forecast to2027 (USD Million)
Figure 59. Middle East and Africa: Chronic Cough Market, by Country, 2019 &2027 (%)
Figure 60. Saudi Arabia: Chronic Cough Market– Revenue and Forecast to 2027(USD Million)
Figure 61. UAE: Chronic Cough Market– Revenue and Forecast to 2027 (USDMillion)
Figure 62. South Africa: Chronic Cough Market– Revenue and Forecast to 2027(USD Million)
Figure 63. South and Central America: Chronic Cough Market, by Key Country –Revenue (2019) (USD Million)
Figure 64. South and Central America Chronic Cough Market Revenue and Forecastto 2027 (USD Million)
Figure 65. South and Central America: Chronic Cough Market, by Country, 2019& 2027 (%)
Figure 66. Brazil: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 67. Argentina: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)
Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
Figure 69. Impact of COVID-19 Pandemic in European Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 71. Impact Of COVID-19 Pandemic in Rest of the World Countries Market
Figure 72. Growth Strategies in The Chronic Cough Market, 2016-2020
The List of Companies - Chronic Cough Market
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- Glaxo Smith Klineplc.
- Bayer AG
- Mylan N.V.
- Amneal Pharmaceuticals, Inc.
- Cipla Inc.
- Reckitt Benckiser Group plc.
- Sun Pharmaceutical Industries Ltd
- AurobindoPharma Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Chronic Cough Market
Jun 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)